Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, if he will make an assessment of the adequacy of the supply of Lisdexamphetamine.

The Department fully understands that maintaining access to lisdexamphentamine is vitally important to many people in this country.

Takeda who market lisdexamphetamine under the brand Elvanse have advised that there were temporary supply issues affecting the Elvanse Adult presentation during September. However, they were able to substitute with an equivalent Elvanse presentation during this time to ensure patients were maintained on treatment. The supply issues are now fully resolved and supplies of all presentations of lisdexamphetamine are currently available in quantities sufficient to meet normal demand.